About Rogers Behavioral Health
Services
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient day treatment or partial hospitalization; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment
Hospitals
Psychiatric hospital
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity
Type of Opioid Treatment
Prescribes buprenorphine; Prescribes naltrexone; Accepts clients using MAT but prescribed elsewhere
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Trauma-related counseling; 12-step facilitation
Facility Operation (e.g., Private, Public)
Private non-profit organization
License/Certification/Accreditation
State mental health department; State department of health; The Joint Commission
Payment/Insurance/Funding Accepted
Medicaid; Private health insurance; Cash or self-payment
Special Programs/Groups Offered
Adolescents; Clients with co-occurring mental and substance use disorders
Assessment/Pre-treatment
Outreach to persons in the community; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Breathalyzer or blood alcohol testing; Drug or alcohol urine screening
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge
Recovery Support Services
Assistance with obtaining social services
Education and Counseling Services
Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Individual counseling; Group counseling; Family counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Children/Adolescents
Gender Accepted
Female; Male
Language Services
Sign language services for the deaf and hard of hearing
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Case management service; Mental health services; Suicide prevention services
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient day treatment or partial hospitalization; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment
Hospitals
Psychiatric hospital
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity
Type of Opioid Treatment
Prescribes buprenorphine; Prescribes naltrexone; Accepts clients using MAT but prescribed elsewhere
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; Trauma-related counseling; 12-step facilitation
Facility Operation (e.g., Private, Public)
Private non-profit organization
License/Certification/Accreditation
State mental health department; State department of health; The Joint Commission
Payment/Insurance/Funding Accepted
Medicaid; Private health insurance; Cash or self-payment
Special Programs/Groups Offered
Adolescents; Clients with co-occurring mental and substance use disorders
Assessment/Pre-treatment
Outreach to persons in the community; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Breathalyzer or blood alcohol testing; Drug or alcohol urine screening
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge
Recovery Support Services
Assistance with obtaining social services
Education and Counseling Services
Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Individual counseling; Group counseling; Family counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Children/Adolescents
Gender Accepted
Female; Male
Language Services
Sign language services for the deaf and hard of hearing
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Case management service; Mental health services; Suicide prevention services
